Form 4: Silvercape Investments acquires 101,000 PETS; holdings rise to 2.58M
Rhea-AI Filing Summary
PetMed Express insider purchase reported. Silvercape Investments Ltd filed a Form 4 showing it acquired 101,000 shares of PETS at $3.17 on 08/13/2025, increasing its direct beneficial ownership to 2,579,696 shares. The filing lists the reporting relationship as Director, shows transaction code P (purchase), and is signed by Peter Kennedy on 08/14/2025.
Positive
- Reported acquisition of 101,000 PETS shares at $3.17 on 08/13/2025
- Direct beneficial ownership increased to 2,579,696 shares following the purchase
- Form 4 includes required signature (Peter Kennedy, dated 08/14/2025)
Negative
- None.
Insights
TL;DR: Director-related entity purchased 101,000 PETS shares, modestly increasing direct ownership to 2.58M shares.
The Form 4 discloses a purchase (transaction code P) of 101,000 common shares at $3.17 per share on 08/13/2025, bringing direct beneficial ownership to 2,579,696 shares. This is a straightforward insider buy reported by Silvercape Investments Ltd with no derivative activity disclosed. The transaction is informative but, without context on company size or market value, its materiality to valuation is unclear from the filing alone.
TL;DR: Filing is complete for the disclosed non-derivative purchase and includes a manual signature.
The Form 4 includes required elements: reporting person name and address, issuer and ticker, transaction date (08/13/2025), transaction details (101,000 shares at $3.17), resulting beneficial ownership, and a signature dated 08/14/2025 by Peter Kennedy. No amendments or derivative transactions are shown. The report meets standard disclosure expectations for Section 16 filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.001 | 101,000 | $3.17 | $320K |